Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from AstraZeneca

AstraZeneca Expects Flat 2022 Covid Sales — Which Is Better Than Expected

AstraZeneca raised its full-year sales guidance on strength from its Covid drugs, leading AZN stock to inch higher early Friday.

Investors Business Daily

AstraZeneca raises sales guidance on demand for Covid treatment

The Anglo-Swedish pharmaceutical giant said it expects the Evusheld Covid-19 injection to help drive sales of at least 20% for the year.

The Independent UK

AstraZeneca claims to have saved six million lives with COVID vaccine

Group profit in the first half of the year spiked by 48% as Michel Demaré lined up for chair

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

AstraZeneca Eyes A Trio Of Drug Approvals And Maybe A Breakout

AstraZeneca announced looming approval for two drugs in Europe and an FDA review for a third med, leading AZN stock to inch higher Monday.

Investors Business Daily

Covid vaccine figures lay bare global inequality as global target missed

Only one in seven people in low-income countries are fully vaccinated with poorest pushed to the ‘back of the queue’

The Guardian - UK

This Is What Whales Are Betting On AstraZeneca

Someone with a lot of money to spend has taken a bearish stance on AstraZeneca (NASDAQ:AZN). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Jabs 'saved half a million people'

A research team from Mahidol University has estimated that the government's Covid-19 vaccination campaign over the past two years prevented nearly 490,000 deaths.

Bangkok Post

Cancer drug found to regenerate a damaged spine

AZD1390 is under investigation by AstraZeneca, who helped develop a Covid-19 vaccine that has seen more than two billion doses released worldwide

Wales Online

Bhutan-China ties won’t harm India’s interests: Bhutan Foreign Minister

After over two years of COVID-19-induced lockdown, Bhutan will open its doors for tourists on September 23 with a new expensive policy for international tourists and Indians as well. Bhutan Foreign Minister Tandi Dorji says the lessons of COVID-19 include better ties with neighbours, including China.

The Hindu

Dow Jones Futures Fall Sharply As Fed Ready For 'Everything'; JPMorgan Earnings Miss

Futures signaled sharp losses for the market rally amid weak JPMorgan earnings and views for a massive Fed rate hike. Tesla's AI chief has left.

Investors Business Daily

The Daily Biotech Pulse: AstraZeneca's COVID-19 Vaccine As Effective As mRNA Shots, Humanigen's Lenzilumab Disappoints In COVID-19 Study, Positive Preclinical Data From Hoth's Alzheimer's Program

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Patent waiver is no silver bullet, even during COVID-19

Unequal access to the COVID-19 vaccine fuelled calls for a patent waiver, but any major change needs to ensure a better outcome for developing economies.

360info

Dow Jones Futures Fall, Crude Dives After Market Rally Runs Into China Wall

Stocks fell from resistance Monday on China news and looming inflation data. Tesla, Twitter and Alibaba were big losers.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

1.1 billion Covid vaccine doses wasted globally, estimates suggest

‘A lot of Covid-19 vaccine wastage has been driven by the deeply unequal global response to this pandemic,’ says global health campaigner

The Conversation

COVID vaccines and pregnancy: a review of the evidence shows they are safe

COVID vaccines have been contentious ever since they were developed in response to the coronavirus pandemic, though the evidence is that they are safe and effective. One of the concerns has been whether the vaccines were safe for pregnant women. A recent review looked at the evidence available from North…

ABC News

Experts say there are a number of factors to weigh up about getting a fourth dose of a COVID-19

As millions more people become eligible for a fourth COVID vaccine dose, you might be asking whether you should book in for it or wait for Omicron-specific vaccines still being developed.

Investors Business Daily

Stocks To Watch: Baidu, UnitedHealth Lead 5 Near Buy Points

Stocks to watch this coming week include a diverse group in or near buy zones, including Baidu and UnitedHealth.

Get all your
news in one place.

100’s of premium titles.
One news app.

ABC News

Thinking of mixing and matching COVID-19 vaccine booster shots? There doesn't seem to be much point

Most people will have the Moderna or the Pfizer vaccine for their fourth dose. But the Doherty Institute's head of vaccine and immunisation research says there's practically no difference between them.

Bangkok Post

Ministry signs contract to buy long-acting antibody drug

The Ministry of Public Health on Wednesday signed a procurement agreement with AstraZeneca for 257,500 doses of the long-acting antibody drug Evusheld, which boosts Covid-19 immunity in patients with low immunity levels.

The Guardian - AU

Canada to throw out 13.6m AstraZeneca Covid vaccine doses amid lack of demand

Government pledged to donate millions of doses to other countries but they were ‘not accepted’ despite fresh rise in coronavirus cases around the world

Wales Online

Canada throwing away 13.6m doses of AstraZeneca Covid vaccine that nobody wants

Oxford AstraZeneca vaccine fell out of favour amid concerns about rare but potentially fatal blood clots

Benzinga

Benzinga Before The Bell: Record Inflows In 'Short Bitcoin' Funds, Elon Musk's Trillionaire Possibility, Gmail's Political Bias And Other Top Financial Stories Tuesday, July 5

Reuters

Investors Business Daily

Dow Jones Futures Fall: Don't Feed The Bear Market; BYD Leaves Tesla In The Dust

Don't feed the bear market, prepare for the next bull run. Tesla deliveries fell sharply in Q2 with BYD on tap.

Benzinga

The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact

Here's a roundup of top developments in the biotech space over the last 24 hours:

1 … 10 11 12 13

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.